Skip to main content
UltraCon 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Learning Lab Additional Fee
Learning Lab Additional Fee
Learing Lab
Learing Lab
Industry
Industry

Therapeutic
Session Type: Industry Session

Bursting bubbles for therapy: Histotripsy's Clinical Frontiers and Technological Innovations with the 2023 FDA Approval

Sunday, April 7, 2024
4:00pm - 5:30pm  
Location:Governor's A - 4th Floor

Industry
A pivotal session exploring the groundbreaking advancements in histotripsy, a new therapeutic approach to tissue ablation using mechanical effects of bubbles produced by high-intensity ultrasound. This session will feature insights from leading experts—clinicians and physicists—who will delve into the latest clinical data and the underlying technology that propelled histotripsy to FDA approval and commercial availability in 2023. A subsequent panel discussion will open the floor for an interactive Q&A with the audience, offering a deep dive into the implications and opportunities of this innovative treatment.

Presentations:

  • 4:00pm - 5:30pm  
    Histotripsy, Clinical

    Timothy Ziemlewicz, MD – University of Wisconsin Department of Radiology

  • 4:00pm - 5:30pm  
    Histotripsy, Technical

    Kenneth B. Bader, PhD – University of Chicago